Magnetic resonance elastography of liver: Technique, analysis, and clinical applications

Journal of Magnetic Resonance Imaging

Volumn 37, Issue 3, 2013, Pages 544-555

  Venkatesh, Sudhakar K ^a,b   Yin, Meng ^b   Ehman, Richard L ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b MAYO CLINIC   (United States)

Author keywords

analysis; clinical applications; fibrosis; liver; magnetic resonance elastography (MRE); technique

Indexed keywords

ACUTE HEPATITIS; ASCITES; BODY MASS; CHRONIC LIVER DISEASE; ECHO PLANAR IMAGING; ELASTOGRAPHY; FOLLOW UP; HEMOSIDEROSIS; HEPATITIS C; HUMAN; IRON OVERLOAD; LIVER FIBROSIS; LIVER INJURY; LIVER PARENCHYMA; LIVER TUMOR; MAGNETIC RESONANCE ELASTOGRAPHY; NON INVASIVE PROCEDURE; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE; OBESITY; PRIORITY JOURNAL; REVIEW; RIGIDITY; SAMPLING ERROR; SENSITIVITY AND SPECIFICITY;

ARTIFACTS; ASCITES; BODY MASS INDEX; ELASTICITY IMAGING TECHNIQUES; EQUIPMENT DESIGN; FATTY LIVER; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; STRESS, MECHANICAL;

EID: 84874226671     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23731     Document Type: Review

References (52)

1. Farci P, Roskams T, Chessa L, et al. Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis. Gastroenterology 2004; 126: 1740-1749.
2. Friedman S, Bansal M,. Reversal of hepatic fibrosis-fact or fantasy? Hepatology 2006; 43: S82-S88.
3. Dixon J, Bhathal P, Hughes N, O'Brien P,. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 2004; 39: 1647-1654.
4. Fowell A, Iredale J,. Emerging therapies for liver fibrosis. Dig Dis 2006; 24: 174-183.
5. Craxi A, Antonucci G, Camma C,. Treatment options in HBV. J Hepatol 2006; 44: S77-S83.
6. Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004; 351: 1521-1531.
7. Dienstag JL, McHutchison JG,. American gastroenterological association technical review on the management of hepatitis C. Gastroenterology 2006; 130: 231-264.
8. Lok AS, McMahon BJ,. Chronic hepatitis B. Hepatology 2007; 45: 507-539.
9. Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB,. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American association for the study of liver diseases. Hepatology 2011; 54: 1433-1444.
10. Leise MD, Kim WR, Canterbury KM, Poterucha JJ,. Drug therapy: telaprevir. Hepatology 2011; 54: 1463-1469.
11. Martinez SM, Crespo G, Navasa M, Forns X,. Noninvasive assessment of liver fibrosis. Hepatology 2011; 53: 325-335.
12. Maharaj B, Maharaj R, Leary W, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523-525.
13. Regev A, Berho M, Jeffers L, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618.
14. Bedossa P, Dargere D, Paradis V,. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457.
15. Piccinino F, Sagnelli E, Pasquale G, Giusti G,. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986; 2: 165-173.
16. Afdhal N, Nunes D,. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004; 99: 1160-1174.
17. Sandrin L, Fourquet B, Hasquenoph J, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-1713.
18. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-350.
19. Girometti R, Furlan A, Bazzocchi M, et al. Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med 2007; 112: 394-408.
20. Lim A, Patel N, Hamilton G, Hajnal J, Goldin R, Taylor-Robinson S,. The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology 2003; 37: 788-794.
21. Muthupillai R, Lomas D, Rossman P, Greenleaf J, Manduca A, Ehman R,. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 1995; 269: 1854-1857.
22. Manduca A, Oliphant T, Dresner M, et al. Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal 2001; 5: 237-254.
23. Rouvière O, Yin M, Dresner M, et al. MR elastography of the liver: preliminary results. Radiology 2006; 240: 440-448.
24. Huwart L, Peeters F, Sinkus R, et al. Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed 2006; 19: 173-179.
25. Yin M, Talwalkar J, Glaser K, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007; 5: 1207-1213. e1202.
26. Huwart L, Sempoux C, Salameh N, et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 2007; 245: 458-466.
27. Huwart L, Sempoux C, Vicaut E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008; 135: 32-40.
28. Asbach P, Klatt D, Hamhaber U, et al. Assessment of liver viscoelasticity using multifrequency MR elastography. Mag Reson Med 2008; 60: 373-379.
29. Bonekamp S, Kamel I, Solga S, Clark J,. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol 2009; 50: 17-35.
30. Hines C, Bley T, Lindstrom M, Reeder S,. Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Reson Imaging 2010; 31: 725-731.
31. Shire NJ, Yin M, Chen J, et al. Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C. J Magn Reson Imaging 2011; 34: 947-955.
32. Motosugi U, Ichikawa T, Sano K, et al. Magnetic Resonance elastography of the liver: preliminary results and estimation of inter-rater reliability. Jpn J Radiol 2010; 28: 623-627.
33. Murphy MC, Glaser KJ, Bolster BD, Litwiller DV, Kruse SA, Ehman RL,. Cross-Platform Comparison of Brain MRE. In: Proceedings of the 19th Annual Meeting of ISMRM, Montreal, 2011. (abstract 1488).
34. Manduca A, Oliphant TE, Dresner MA, et al. Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal 2001; 5: 237-254.
35. Oliphant TE, Manduca A, Ehman RL, Greenleaf JF,. Complex-valued stiffness reconstruction for magnetic resonance elastography by algebraic inversion of the differential equation. Magn Reson Med 2001; 45: 299-310.
36. Manduca A, Lake D, Kruse S, Ehman R,. Spatio-temporal directional filtering for improved inversion of MR elastography images. Med Image Anal 2003; 7: 465-473.
37. Huwart L, Salameh N, ter Beek L, et al. MR elastography of liver fibrosis: preliminary results comparing spin-echo and echo-planar imaging. Eur Radiol 2008; 18: 2535-2541.
38. Asbach P, Klatt D, Schlosser B, et al. Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR Elastography. Radiology 2010; 257: 80-86.
39. Wang Y, Ganger DR, Levitsky J, et al. Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 2011; 196: 553-561.
40. Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008; 47: 380-384.
41. Silva AC, Walker FB, Vargas HE, Jatoi MA, Ehman RL,. Diffuse liver disease: virtual palpation with MR elastography. In: Proceedings of the Radiological Society of North America 93rd Scientific Assembly and Annual Meeting, Chicago, IL. 2008.
42. Marcellin P, Asselah T, Boyer N,. Fibrosis and disease progression in hepatitis C. Hepatology 2002; 36: S47-S56.
43. Lee VS, Miller FH, Omary RA, et al. Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients. Transplantation 2011; 92: 581-586.
44. Mederacke I, Wursthorn K, Kirschner J, et al. Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int 2009; 29: 1500-1506.
45. Yin M, Talwalkar JA, Glaser KJ, et al. Dynamic postprandial hepatic stiffness augmentation assessed with MR elastography in patients with chronic liver disease. AJR Am J Roentgenol 2011; 197: 64-70.
46. Venkatesh SK, Teo LLS, Ang BWL, Lim SG, Wee A, Ehman RL,. Effect of intravenous gadolinium on estimation of liver stiffness with MR elastography. In: European Congress of Radiology 2010. Vienna, Austria: European Society of Radiology, 2010. (abstract 163).
47. Bensamoun SF, Wang L, Robert L, Charleux F, Latrive JP, Ho Ba Tho MC,. Measurement of liver stiffness with two imaging techniques: magnetic resonance elastography and ultrasound elastometry. J Magn Reson Imaging 2008; 28: 1287-1292.
48. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL,. Early Detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011; 259: 749-756.
49. Venkatesh S, Yin M, Glockner J, et al. MR elastography of liver tumors: preliminary results. AJR Am J Roentgenol 2008; 190: 1534-1540.
50. Taouli B, Ehman R, Reeder S,. Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol 2009; 193: 14-27.
51. Stanley DW, Glaser KJ, Yin M, Chen J, Ehman RL,. Validity study of spin echo epi based hepatic MR elastography at 3.0T. In: Proceedings of the 18th Annual Meeting of ISMRM, Montreal, 2010. (abstract 629).
52. Hoganson DD, Chen J, Ehman RL, et al. Magnetic resonance elastography for the evaluation of liver fibrosis in patients with rheumatoid arthritis receiving methotrexate. [abstract]. Arthritis Rheum 2010; 62 (Suppl 10): 129 doi:10.1002/art.27898.